Evidence map›Paper›PMID 34003877›Full record

ArticlePloS one2021

Physical properties of lactic acid bacteria influence the level of protection against influenza infection in mice.

Takumi Watanabe, Kyoko Hayashi, Isao Takahashi, Makoto Ohwaki, Tatsuhiko Kan, Toshio Kawahara

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Takumi WatanabeBio-Lab Co., Ltd., Hidaka, Saitama, Japan.ORCID 0000-0002-4607-0747
Kyoko HayashiGraduate School of Engineering, Chubu University, Kasugai, Japan.
Isao TakahashiICAM Co., Ltd., Itabashi, Tokyo, Japan.
Makoto OhwakiNon-Profit Organisation, The Japanese Association of Clinical Research on Supplements, Hidaka, Saitama, Japan.
Tatsuhiko KanBio-Lab Co., Ltd., Hidaka, Saitama, Japan.
Toshio KawaharaCollege of Life and Health Sciences, Chubu University, Kasugai, Japan.
Chubu University · JPJapan Clinical Cancer Research Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated whether the water dispersibility of lactic acid bacteria (Enterococcus faecalis KH2) affects their efficacy. When cultured lactic acid bacteria are washed, heat-killed, and powdered, adhesion occurs between results in aggregation (non-treated lactic acid bacteria, n-LAB). However, dispersed lactic acid bacteria (d-LAB) with a lower number of aggregates can be prepared by treating them with a high-pressure homogenizer and adding an excipient during powdering. Mice were administered n-LAB or d-LAB Peyer's patches in the small intestine were observed. Following n-LAB administration, a high amount of aggregated bacteria drifting in the intestinal mucosa was observed; meanwhile, d-LAB reached the Peyer's patches and was absorbed into them. Evaluation in a mouse influenza virus infection model showed that d-LAB was more effective than n-LAB in the influenza yield of bronchoalveolar lavage fluids on day 3 post-infection and neutralizing antibody titers of sera and influenza virus-specific immunoglobulin A in the feces on day 14 post-infection. Therefore, the physical properties of lactic acid bacteria affect their efficacy; controlling their water dispersibility can improve their effectiveness.

Indexed as

Enterococcus faecalisOrthomyxoviridae InfectionsAnimalsAntibodies, NeutralizingAntibodies, ViralBronchoalveolar Lavage FluidImmunoglobulin AInfluenza A virusLungMaleMicePeyer's PatchesAntibodies, NeutralizingAntibodies, ViralImmunoglobulin A

Identifiers

PMID34003877
PMCPMC8130949
OpenAlexW3162337247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.